TotalMarketCap

NeuroSense Therapeutics

NRSNNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.751 M

$1.45 +2.11%

Close of 6 Nov 2026

As of 6 Nov 2026, NeuroSense Therapeutics (NRSN) has a market capitalization of $2.75M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$11.1M

Loss-making

Shares outstanding

32,557,174

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

NeuroSense Therapeutics lists more than one class of stock. Company figures above cover all classes combined.

NRSNW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #473Clearmind MedicineCMND$2.90M
  2. #474Jupiter NeurosciencesJUNS$2.88M
  3. #475NeuroSense TherapeuticsNRSN$2.75M
  4. #476Decoy TherapeuticsDCOY$2.70M
  5. #477PRF TechnologiesPRFX$2.64M

What if NeuroSense Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$14,885,784

Per share 10,266,058× higher

Bitcoin $1.53T

$805,443.83

Per share 555,479× higher

Apple $5.02T

$2,644,197

Per share 1,823,584× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for NeuroSense Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.